Log in to save to my catalogue

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with...

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cbbadef41cb14a1b91639138a1f60fcb

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A significant proportion of patients with oestrogen receptor (ER) positive breast cancers (BC) develop resistance to endocrine treatments (ET) and relapse with metastatic disease. Here we perform whole exome sequencing and gene expression analysis of matched primary breast tumours and bone metastasis-derived patient-derived xenografts (PDX). Transc...

Alternative Titles

Full title

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cbbadef41cb14a1b91639138a1f60fcb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cbbadef41cb14a1b91639138a1f60fcb

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-17697-1

How to access this item